Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.51%
#2 SAFEcoin SAFEcoin +29.03%
#3 Zora Zora +27.23%
#4 Pons Pons +27.21%
#5 0G 0G +25.84%
#6 QuantixAI QuantixAI +24.35%
#7 AI XOVIA AI XOVIA +18.73%
#8 Verus Coin Verus Coin +17.85%
#9 StonkBroker StonkBroker +17.56%
#10 ADO Protocol ADO Protocol +17.06%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Pozycja w akcjach #13233
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Cena akcji
$4.99
Kapitalizacja rynkowa
$508.03M
Zmiana (1 dzień)
-2.48%
Zmiana (1 rok)
2.10%
Kraj
TW
Handel Ever Supreme Bio Technology Co., Ltd (6712)

Kategoria

Healthcare
Zyski dla Ever Supreme Bio Technology Co., Ltd (6712)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Ever Supreme Bio Technology Co., Ltd, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Ever Supreme Bio Technology Co., Ltd od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH